“Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s154. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/1980.